While GBP-5 has been associated with improved prognosis in breast cancers [16,26,28], one group of investigators published that GBP-5 correlated with good prognosis in TNBC samples [26] and then used a different set of array data to suggest it correlated with poor prognosis [27]. This evidence concerns the gene GBP5 and breast carcinoma.